Abstract
Differences in dopaminergic motor response in Parkinson’s disease (PD) patients are related to specific PD subtypes. An important factor driving dopaminergic response might lie in the temporal dynamics in corticostriatal connections. The aim of this study is to determine if altered resting-state dynamic functional network connectivity (dFNC) is associated with dopaminergic motor response. We assessed static and dFNC in 32 PD patients and 18 healthy controls (HC). Patients were subgrouped according to their dopaminergic motor response as low and high responders using a median split. Results showed that patients featuring high dopaminergic responses spent more time in a regionally more integrated state (State 1) compared to HC. Furthermore, dFNC between the anterior midcingulate cortex/dorsal anterior cingulate cortex (aMCC/dACC) and the putamen was lower in low responders during a more segregated state (State 2) and correlated with dopaminergic motor response. Alterations in temporal dynamics of fronto-striatal connectivity might underlie treatment response in PD.
Introduction
Parkinson’s Disease (PD) is characterized by the progressive loss of dopaminergic neurons, traditionally managed through dopamine replacement therapies like Levodopa. However, clinical outcomes are notoriously heterogeneous; while some patients experience significant motor recovery, others—despite a confirmed diagnosis—show a limited response to medication.
Traditional neuroimaging has struggled to explain this variance, largely because it relies on "static" functional connectivity, which averages brain activity over several minutes. This approach often misses the transient, millisecond-to-second shifts in neural communication. This study investigates whether the secret to treatment response lies in dynamic functional network connectivity (dFNC)—the fluidity with which the brain transitions between different organizational states.
Methodology
Participants and Clinical Assessment
The study included 32 PD patients and 18 age- and sex-matched healthy controls (HC). To quantify treatment response, patients were evaluated using the MDS-Unified Parkinson’s Disease Rating Scale (UPDRS) Part III in two conditions: an "OFF" state (following a 12-hour medication withdrawal) and an "ON" state (during regular medication). Patients were categorized into "high" and "low" responders based on a median split of their motor improvement scores.
Imaging and Analysis Pipeline
Participants underwent resting-state functional MRI (fMRI). The analysis followed a rigorous pipeline:
- Independent Component Analysis (ICA): Ten Volumes of Interest (VOIs) were identified across four motor-related systems: sensorimotor, motor initiation, basal ganglia, and cerebellar networks. These were constrained using a reference dataset of 405 healthy controls to ensure biological robustness.
- Sliding Window Approach: Rather than averaging the entire scan, the researchers used 44-second windows, sliding them across the timeline to capture evolving connectivity patterns.
- k-means Clustering: These transient patterns were grouped into two distinct states:
- State 1 (Integrated): High connectivity between disparate networks (e.g., cortex-to-striatum communication).
- State 2 (Segregated): "Siloed" activity where networks operate in relative isolation.
Key Findings
The Failure of Static Connectivity
A pivotal finding of this research is that static connectivity metrics failed to differentiate between high and low responders. The biomarkers of treatment efficacy only became visible when the temporal dynamics of the brain were analyzed, suggesting that the "average" wiring of the PD brain is less informative than its ability to shift between states.
The "Integrated" Advantage
High responders spent significantly more time in State 1 (the integrated state) compared to healthy controls ($P = 0.010$). This suggests that a brain capable of maintaining a highly integrated state may be better "primed" to utilize exogenous dopamine. This integration likely allows the effects of medication to propagate more effectively across the motor hierarchy.
The Fronto-Striatal Deficit
In the more segregated State 2, low responders exhibited significantly lower connectivity between the putamen (a critical motor hub) and the aMCC/dACC (regions involved in motor initiation and motivation). This specific connectivity dip correlated strongly with the magnitude of the patient's clinical response ($r = 0.59, P = 0.002$). Notably, high and low responders did not differ in age, disease duration, or baseline severity, indicating that these connectivity patterns are an independent biomarker of drug efficacy rather than a proxy for disease progression.
Discussion and Limitations
These results suggest that the ability to maintain integration between the cortex and the striatum is a hallmark of a positive dopaminergic response. While some models of PD emphasize a "loss of segregation" as a pathological feature, this study highlights that the preservation of integration is what facilitates clinical recovery.
However, several limitations must be considered:
- Medication Bias: fMRI data were collected while patients were in their "ON" state. It remains unclear if these connectivity patterns are the cause of a good response or a manifestation of the medication's success.
- Sample Size: The cohort of 50 participants is relatively small, requiring validation in larger, multi-center studies.
- Standardization: The use of regular medication regimens instead of a standardized Levodopa challenge may introduce variability in the "ON" state measurements.
Conclusion
Fronto-striatal dynamic connectivity offers a promising new lens through which to view treatment heterogeneity in Parkinson’s Disease. By identifying the specific temporal states that correlate with motor improvement, clinicians may eventually be able to use dFNC as a predictive tool to tailor therapies for individual patients, moving closer to a personalized medicine approach in neurology.
Summary updated